nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.15	0.263	CbGbCtD
Orphenadrine—CYP2E1—Etoposide—uterine cancer	0.147	0.258	CbGbCtD
Orphenadrine—CYP3A4—Progesterone—uterine cancer	0.0996	0.174	CbGbCtD
Orphenadrine—CYP2B6—Doxorubicin—uterine cancer	0.0989	0.173	CbGbCtD
Orphenadrine—CYP3A4—Etoposide—uterine cancer	0.0446	0.078	CbGbCtD
Orphenadrine—CYP3A4—Doxorubicin—uterine cancer	0.0304	0.0532	CbGbCtD
Orphenadrine—Aplastic anaemia—Dactinomycin—uterine cancer	0.00888	0.0329	CcSEcCtD
Orphenadrine—Drowsiness—Progesterone—uterine cancer	0.00749	0.0277	CcSEcCtD
Orphenadrine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00678	0.0251	CcSEcCtD
Orphenadrine—Tension—Progesterone—uterine cancer	0.00574	0.0213	CcSEcCtD
Orphenadrine—Vision blurred—Progesterone—uterine cancer	0.00551	0.0204	CcSEcCtD
Orphenadrine—Tremor—Progesterone—uterine cancer	0.00548	0.0203	CcSEcCtD
Orphenadrine—Toremifene—ESR1—uterine cancer	0.00524	0.274	CrCbGaD
Orphenadrine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.0052	0.0193	CcSEcCtD
Orphenadrine—Palpitations—Progesterone—uterine cancer	0.00517	0.0192	CcSEcCtD
Orphenadrine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00497	0.0184	CcSEcCtD
Orphenadrine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00487	0.0181	CcSEcCtD
Orphenadrine—Confusional state—Progesterone—uterine cancer	0.00481	0.0178	CcSEcCtD
Orphenadrine—Anaphylactic shock—Progesterone—uterine cancer	0.00477	0.0177	CcSEcCtD
Orphenadrine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00468	0.0174	CcSEcCtD
Orphenadrine—Tachycardia—Progesterone—uterine cancer	0.00466	0.0173	CcSEcCtD
Orphenadrine—Skin disorder—Progesterone—uterine cancer	0.00464	0.0172	CcSEcCtD
Orphenadrine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00436	0.0162	CcSEcCtD
Orphenadrine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00433	0.016	CcSEcCtD
Orphenadrine—Somnolence—Progesterone—uterine cancer	0.00424	0.0157	CcSEcCtD
Orphenadrine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00422	0.0156	CcSEcCtD
Orphenadrine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.0042	0.0156	CcSEcCtD
Orphenadrine—Constipation—Progesterone—uterine cancer	0.00408	0.0151	CcSEcCtD
Orphenadrine—Feeling abnormal—Progesterone—uterine cancer	0.00393	0.0146	CcSEcCtD
Orphenadrine—Levomethadyl Acetate—CYP19A1—uterine cancer	0.00385	0.201	CrCbGaD
Orphenadrine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00385	0.0143	CcSEcCtD
Orphenadrine—Urticaria—Progesterone—uterine cancer	0.00379	0.0141	CcSEcCtD
Orphenadrine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.0037	0.0137	CcSEcCtD
Orphenadrine—Aplastic anaemia—Epirubicin—uterine cancer	0.0036	0.0134	CcSEcCtD
Orphenadrine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00356	0.0132	CcSEcCtD
Orphenadrine—Hypersensitivity—Progesterone—uterine cancer	0.00352	0.013	CcSEcCtD
Orphenadrine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00344	0.0127	CcSEcCtD
Orphenadrine—Asthenia—Progesterone—uterine cancer	0.00343	0.0127	CcSEcCtD
Orphenadrine—Tamoxifen—ESR2—uterine cancer	0.0034	0.178	CrCbGaD
Orphenadrine—Pruritus—Progesterone—uterine cancer	0.00338	0.0125	CcSEcCtD
Orphenadrine—Aplastic anaemia—Doxorubicin—uterine cancer	0.00333	0.0124	CcSEcCtD
Orphenadrine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00319	0.0118	CcSEcCtD
Orphenadrine—Dizziness—Progesterone—uterine cancer	0.00316	0.0117	CcSEcCtD
Orphenadrine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.0031	0.0115	CcSEcCtD
Orphenadrine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00306	0.0113	CcSEcCtD
Orphenadrine—Vomiting—Progesterone—uterine cancer	0.00304	0.0113	CcSEcCtD
Orphenadrine—Headache—Progesterone—uterine cancer	0.00299	0.0111	CcSEcCtD
Orphenadrine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00286	0.0106	CcSEcCtD
Orphenadrine—Nausea—Progesterone—uterine cancer	0.00284	0.0105	CcSEcCtD
Orphenadrine—Feeling abnormal—Dactinomycin—uterine cancer	0.00278	0.0103	CcSEcCtD
Orphenadrine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00275	0.0102	CcSEcCtD
Orphenadrine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00271	0.01	CcSEcCtD
Orphenadrine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00257	0.00952	CcSEcCtD
Orphenadrine—Hypersensitivity—Dactinomycin—uterine cancer	0.00249	0.00921	CcSEcCtD
Orphenadrine—Confusional state—Etoposide—uterine cancer	0.00246	0.00913	CcSEcCtD
Orphenadrine—Anaphylactic shock—Etoposide—uterine cancer	0.00244	0.00905	CcSEcCtD
Orphenadrine—Asthenia—Dactinomycin—uterine cancer	0.00242	0.00897	CcSEcCtD
Orphenadrine—Tachycardia—Etoposide—uterine cancer	0.00238	0.00883	CcSEcCtD
Orphenadrine—Skin disorder—Etoposide—uterine cancer	0.00237	0.00879	CcSEcCtD
Orphenadrine—Tamoxifen—CYP19A1—uterine cancer	0.00228	0.119	CrCbGaD
Orphenadrine—Methadone—CYP19A1—uterine cancer	0.00226	0.118	CrCbGaD
Orphenadrine—Somnolence—Etoposide—uterine cancer	0.00217	0.00805	CcSEcCtD
Orphenadrine—Drowsiness—Epirubicin—uterine cancer	0.00215	0.00796	CcSEcCtD
Orphenadrine—Vomiting—Dactinomycin—uterine cancer	0.00215	0.00795	CcSEcCtD
Orphenadrine—Tamoxifen—ESR1—uterine cancer	0.00209	0.11	CrCbGaD
Orphenadrine—Constipation—Etoposide—uterine cancer	0.00209	0.00774	CcSEcCtD
Orphenadrine—Feeling abnormal—Etoposide—uterine cancer	0.00201	0.00746	CcSEcCtD
Orphenadrine—Nausea—Dactinomycin—uterine cancer	0.002	0.00743	CcSEcCtD
Orphenadrine—Drowsiness—Doxorubicin—uterine cancer	0.00199	0.00736	CcSEcCtD
Orphenadrine—Urticaria—Etoposide—uterine cancer	0.00194	0.00719	CcSEcCtD
Orphenadrine—Hypersensitivity—Etoposide—uterine cancer	0.0018	0.00667	CcSEcCtD
Orphenadrine—Asthenia—Etoposide—uterine cancer	0.00175	0.00649	CcSEcCtD
Orphenadrine—Pruritus—Etoposide—uterine cancer	0.00173	0.0064	CcSEcCtD
Orphenadrine—Tension—Epirubicin—uterine cancer	0.00165	0.0061	CcSEcCtD
Orphenadrine—Dizziness—Etoposide—uterine cancer	0.00161	0.00599	CcSEcCtD
Orphenadrine—Vision blurred—Epirubicin—uterine cancer	0.00158	0.00586	CcSEcCtD
Orphenadrine—Vomiting—Etoposide—uterine cancer	0.00155	0.00576	CcSEcCtD
Orphenadrine—Agitation—Epirubicin—uterine cancer	0.00154	0.00571	CcSEcCtD
Orphenadrine—Headache—Etoposide—uterine cancer	0.00153	0.00567	CcSEcCtD
Orphenadrine—Tension—Doxorubicin—uterine cancer	0.00152	0.00564	CcSEcCtD
Orphenadrine—Palpitations—Epirubicin—uterine cancer	0.00148	0.00549	CcSEcCtD
Orphenadrine—Vision blurred—Doxorubicin—uterine cancer	0.00146	0.00542	CcSEcCtD
Orphenadrine—Nausea—Etoposide—uterine cancer	0.00145	0.00538	CcSEcCtD
Orphenadrine—Agitation—Doxorubicin—uterine cancer	0.00143	0.00529	CcSEcCtD
Orphenadrine—Confusional state—Epirubicin—uterine cancer	0.00138	0.00512	CcSEcCtD
Orphenadrine—Palpitations—Doxorubicin—uterine cancer	0.00137	0.00508	CcSEcCtD
Orphenadrine—Anaphylactic shock—Epirubicin—uterine cancer	0.00137	0.00507	CcSEcCtD
Orphenadrine—Tachycardia—Epirubicin—uterine cancer	0.00134	0.00495	CcSEcCtD
Orphenadrine—Skin disorder—Epirubicin—uterine cancer	0.00133	0.00493	CcSEcCtD
Orphenadrine—Confusional state—Doxorubicin—uterine cancer	0.00128	0.00473	CcSEcCtD
Orphenadrine—Anaphylactic shock—Doxorubicin—uterine cancer	0.00127	0.00469	CcSEcCtD
Orphenadrine—Tachycardia—Doxorubicin—uterine cancer	0.00124	0.00458	CcSEcCtD
Orphenadrine—Skin disorder—Doxorubicin—uterine cancer	0.00123	0.00456	CcSEcCtD
Orphenadrine—Somnolence—Epirubicin—uterine cancer	0.00122	0.00451	CcSEcCtD
Orphenadrine—Constipation—Epirubicin—uterine cancer	0.00117	0.00434	CcSEcCtD
Orphenadrine—Feeling abnormal—Epirubicin—uterine cancer	0.00113	0.00418	CcSEcCtD
Orphenadrine—Somnolence—Doxorubicin—uterine cancer	0.00113	0.00417	CcSEcCtD
Orphenadrine—Urticaria—Epirubicin—uterine cancer	0.00109	0.00403	CcSEcCtD
Orphenadrine—Constipation—Doxorubicin—uterine cancer	0.00108	0.00401	CcSEcCtD
Orphenadrine—Feeling abnormal—Doxorubicin—uterine cancer	0.00104	0.00387	CcSEcCtD
Orphenadrine—Hypersensitivity—Epirubicin—uterine cancer	0.00101	0.00374	CcSEcCtD
Orphenadrine—Urticaria—Doxorubicin—uterine cancer	0.00101	0.00373	CcSEcCtD
Orphenadrine—Asthenia—Epirubicin—uterine cancer	0.000982	0.00364	CcSEcCtD
Orphenadrine—Pruritus—Epirubicin—uterine cancer	0.000969	0.00359	CcSEcCtD
Orphenadrine—Hypersensitivity—Doxorubicin—uterine cancer	0.000933	0.00346	CcSEcCtD
Orphenadrine—Asthenia—Doxorubicin—uterine cancer	0.000909	0.00337	CcSEcCtD
Orphenadrine—Dizziness—Epirubicin—uterine cancer	0.000905	0.00336	CcSEcCtD
Orphenadrine—Pruritus—Doxorubicin—uterine cancer	0.000896	0.00332	CcSEcCtD
Orphenadrine—Vomiting—Epirubicin—uterine cancer	0.00087	0.00323	CcSEcCtD
Orphenadrine—Headache—Epirubicin—uterine cancer	0.000858	0.00318	CcSEcCtD
Orphenadrine—Dizziness—Doxorubicin—uterine cancer	0.000838	0.0031	CcSEcCtD
Orphenadrine—Nausea—Epirubicin—uterine cancer	0.000813	0.00301	CcSEcCtD
Orphenadrine—Vomiting—Doxorubicin—uterine cancer	0.000805	0.00298	CcSEcCtD
Orphenadrine—Headache—Doxorubicin—uterine cancer	0.000793	0.00294	CcSEcCtD
Orphenadrine—Nausea—Doxorubicin—uterine cancer	0.000752	0.00279	CcSEcCtD
Orphenadrine—SCN1A—Developmental Biology—MET—uterine cancer	0.000291	0.00208	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—SMAD3—uterine cancer	0.000291	0.00207	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.00029	0.00207	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—MET—uterine cancer	0.000287	0.00205	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000281	0.002	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—HRAS—uterine cancer	0.000279	0.00199	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—PIK3CA—uterine cancer	0.000277	0.00198	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000272	0.00194	CbGpPWpGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	0.000266	0.0019	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—HRAS—uterine cancer	0.00026	0.00185	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—VEGFA—uterine cancer	0.000259	0.00185	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—NRAS—uterine cancer	0.000256	0.00183	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—SMAD3—uterine cancer	0.00025	0.00178	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—ERBB2—uterine cancer	0.000244	0.00174	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—ERBB2—uterine cancer	0.00024	0.00171	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—VEGFA—uterine cancer	0.000238	0.0017	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—MET—uterine cancer	0.000238	0.0017	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000238	0.0017	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—NRAS—uterine cancer	0.000235	0.00168	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—VEGFA—uterine cancer	0.00023	0.00164	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—VEGFA—uterine cancer	0.00023	0.00164	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—AKT1—uterine cancer	0.000229	0.00164	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—NRAS—uterine cancer	0.000227	0.00162	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—NRAS—uterine cancer	0.000227	0.00162	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—AKT1—uterine cancer	0.000227	0.00162	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—ERBB2—uterine cancer	0.000221	0.00158	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—KRAS—uterine cancer	0.00022	0.00157	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—HRAS—uterine cancer	0.000214	0.00152	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—ERBB2—uterine cancer	0.000213	0.00152	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—ERBB2—uterine cancer	0.000213	0.00152	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—CTNNB1—uterine cancer	0.00021	0.0015	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—ERBB2—uterine cancer	0.00021	0.0015	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.000209	0.00149	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—MET—uterine cancer	0.000205	0.00146	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—KRAS—uterine cancer	0.000203	0.00145	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—HRAS—uterine cancer	0.0002	0.00143	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	0.000196	0.0014	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—EP300—uterine cancer	0.000195	0.00139	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—KRAS—uterine cancer	0.000195	0.00139	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—KRAS—uterine cancer	0.000195	0.00139	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000194	0.00138	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—CTNNB1—uterine cancer	0.000193	0.00138	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—VEGFA—uterine cancer	0.000188	0.00134	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—HRAS—uterine cancer	0.000187	0.00134	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—CTNNB1—uterine cancer	0.000186	0.00133	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—CTNNB1—uterine cancer	0.000186	0.00133	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—NRAS—uterine cancer	0.000186	0.00132	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—VEGFA—uterine cancer	0.000185	0.00132	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.000184	0.00131	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	0.000183	0.00131	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—NRAS—uterine cancer	0.000183	0.0013	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—EP300—uterine cancer	0.00018	0.00128	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—ERBB2—uterine cancer	0.000174	0.00124	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—EP300—uterine cancer	0.000173	0.00124	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—EP300—uterine cancer	0.000173	0.00124	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—HRAS—uterine cancer	0.000172	0.00123	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NDUFB11—uterine cancer	0.000171	0.00122	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SRD5A2—uterine cancer	0.000171	0.00122	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—VEGFA—uterine cancer	0.00017	0.00121	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.00017	0.00121	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—NRAS—uterine cancer	0.000168	0.0012	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SRD5A2—uterine cancer	0.000167	0.00119	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NDUFB11—uterine cancer	0.000167	0.00119	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—HRAS—uterine cancer	0.000166	0.00118	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—HRAS—uterine cancer	0.000166	0.00118	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—VEGFA—uterine cancer	0.000164	0.00117	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—VEGFA—uterine cancer	0.000164	0.00117	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—NRAS—uterine cancer	0.000162	0.00116	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—NRAS—uterine cancer	0.000162	0.00116	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—VEGFA—uterine cancer	0.000162	0.00115	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—KRAS—uterine cancer	0.00016	0.00114	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—NRAS—uterine cancer	0.00016	0.00114	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000158	0.00113	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—KRAS—uterine cancer	0.000157	0.00112	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—NRAS—uterine cancer	0.000153	0.00109	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—HRAS—uterine cancer	0.000153	0.00109	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—CTNNB1—uterine cancer	0.000152	0.00109	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—ERBB2—uterine cancer	0.00015	0.00107	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000149	0.00107	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	0.000145	0.00103	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—KRAS—uterine cancer	0.000145	0.00103	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	0.000143	0.00102	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—EP300—uterine cancer	0.000142	0.00101	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—KRAS—uterine cancer	0.000139	0.000995	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—KRAS—uterine cancer	0.000139	0.000995	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—KRAS—uterine cancer	0.000137	0.00098	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—HRAS—uterine cancer	0.000136	0.000969	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.000136	0.000967	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—VEGFA—uterine cancer	0.000134	0.000957	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—HRAS—uterine cancer	0.000134	0.000954	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.000133	0.000952	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—CXCL8—uterine cancer	0.000133	0.000946	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—NRAS—uterine cancer	0.000132	0.000945	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—KRAS—uterine cancer	0.000132	0.000941	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—CTNNB1—uterine cancer	0.000131	0.000934	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKR1B10—uterine cancer	0.00013	0.000928	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKR1B10—uterine cancer	0.000128	0.000913	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—HRAS—uterine cancer	0.000128	0.00091	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—STAR—uterine cancer	0.000124	0.000882	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKR1B1—uterine cancer	0.000124	0.000882	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—HRAS—uterine cancer	0.000123	0.000877	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—EP300—uterine cancer	0.000122	0.000868	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—uterine cancer	0.000121	0.000864	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKR1B1—uterine cancer	0.000121	0.000864	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—STAR—uterine cancer	0.000121	0.000864	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—HRAS—uterine cancer	0.000118	0.000845	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—HRAS—uterine cancer	0.000118	0.000845	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—AKT1—uterine cancer	0.000118	0.000842	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—HRAS—uterine cancer	0.000117	0.000833	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—uterine cancer	0.000116	0.000828	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—VEGFA—uterine cancer	0.000115	0.000822	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—KRAS—uterine cancer	0.000114	0.000814	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—NRAS—uterine cancer	0.000114	0.000812	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—AKT1—uterine cancer	0.000108	0.000774	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RNF43—uterine cancer	0.000108	0.000769	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000107	0.000765	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RNF43—uterine cancer	0.000106	0.000756	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000105	0.000752	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—AKT1—uterine cancer	0.000105	0.000746	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—AKT1—uterine cancer	0.000105	0.000746	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CCL2—uterine cancer	0.000103	0.000736	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—PIK3CA—uterine cancer	0.000103	0.000732	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CCL2—uterine cancer	0.000102	0.000725	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	9.99e-05	0.000713	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—INHBA—uterine cancer	9.85e-05	0.000703	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—KRAS—uterine cancer	9.8e-05	0.000699	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—POLD1—uterine cancer	9.7e-05	0.000692	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—INHBA—uterine cancer	9.7e-05	0.000692	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—HRAS—uterine cancer	9.69e-05	0.000692	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—POLD1—uterine cancer	9.5e-05	0.000678	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	9.18e-05	0.000655	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKR1C1—uterine cancer	9.07e-05	0.000647	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKR1C1—uterine cancer	8.88e-05	0.000634	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKR1C1—uterine cancer	8.87e-05	0.000633	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKR1C1—uterine cancer	8.73e-05	0.000623	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—AKT1—uterine cancer	8.56e-05	0.000611	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	8.49e-05	0.000606	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—HRAS—uterine cancer	8.33e-05	0.000594	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CXCL8—uterine cancer	8.16e-05	0.000582	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—RRM2—uterine cancer	8.08e-05	0.000577	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CXCL8—uterine cancer	8.03e-05	0.000573	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—RRM2—uterine cancer	7.92e-05	0.000565	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—DCN—uterine cancer	7.85e-05	0.00056	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NDUFB11—uterine cancer	7.77e-05	0.000554	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SRD5A2—uterine cancer	7.77e-05	0.000554	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—DCN—uterine cancer	7.69e-05	0.000548	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP11A1—uterine cancer	7.39e-05	0.000528	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—AKT1—uterine cancer	7.35e-05	0.000525	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP11A1—uterine cancer	7.24e-05	0.000517	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKR1C3—uterine cancer	6.98e-05	0.000498	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKR1C3—uterine cancer	6.84e-05	0.000488	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKR1C3—uterine cancer	6.83e-05	0.000487	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKR1C3—uterine cancer	6.72e-05	0.00048	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PGR—uterine cancer	6.66e-05	0.000475	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PGR—uterine cancer	6.55e-05	0.000467	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—YWHAE—uterine cancer	6.35e-05	0.000453	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—YWHAE—uterine cancer	6.25e-05	0.000446	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FBXW7—uterine cancer	6.09e-05	0.000434	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FBXW7—uterine cancer	5.99e-05	0.000427	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKR1B1—uterine cancer	5.62e-05	0.000401	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—STAR—uterine cancer	5.62e-05	0.000401	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—STK11—uterine cancer	5.44e-05	0.000388	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP19A1—uterine cancer	5.44e-05	0.000388	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—STK11—uterine cancer	5.33e-05	0.00038	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP19A1—uterine cancer	5.33e-05	0.00038	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STK11—uterine cancer	5.32e-05	0.00038	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCL2—uterine cancer	5.3e-05	0.000378	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STK11—uterine cancer	5.24e-05	0.000374	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCL2—uterine cancer	5.21e-05	0.000372	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SOCS3—uterine cancer	4.98e-05	0.000356	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SOCS3—uterine cancer	4.9e-05	0.00035	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN2B—uterine cancer	4.77e-05	0.00034	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN2B—uterine cancer	4.69e-05	0.000335	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1R—uterine cancer	4.63e-05	0.000331	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCL8—uterine cancer	4.61e-05	0.000329	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1R—uterine cancer	4.56e-05	0.000325	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCL8—uterine cancer	4.54e-05	0.000324	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—POLD1—uterine cancer	4.41e-05	0.000314	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SMAD3—uterine cancer	4.36e-05	0.000311	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SMAD3—uterine cancer	4.29e-05	0.000306	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCL8—uterine cancer	4.19e-05	0.000299	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGFR2—uterine cancer	4.15e-05	0.000296	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.12e-05	0.000294	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCL8—uterine cancer	4.12e-05	0.000294	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MTHFR—uterine cancer	4.09e-05	0.000292	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGFR2—uterine cancer	4.09e-05	0.000292	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MTHFR—uterine cancer	4e-05	0.000286	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—RRM2—uterine cancer	3.67e-05	0.000262	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—DCN—uterine cancer	3.57e-05	0.000254	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ESR1—uterine cancer	3.55e-05	0.000254	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ESR1—uterine cancer	3.5e-05	0.00025	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP11A1—uterine cancer	3.36e-05	0.00024	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—NRAS—uterine cancer	3.36e-05	0.00024	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—NRAS—uterine cancer	3.31e-05	0.000236	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.17e-05	0.000226	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL2—uterine cancer	3.13e-05	0.000223	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL2—uterine cancer	3.08e-05	0.00022	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CA—uterine cancer	2.93e-05	0.000209	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—KRAS—uterine cancer	2.89e-05	0.000206	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CA—uterine cancer	2.88e-05	0.000205	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—KRAS—uterine cancer	2.85e-05	0.000203	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	2.66e-05	0.00019	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CA—uterine cancer	2.61e-05	0.000187	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ERBB2—uterine cancer	2.61e-05	0.000186	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ERBB2—uterine cancer	2.57e-05	0.000183	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL8—uterine cancer	2.47e-05	0.000177	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—STK11—uterine cancer	2.47e-05	0.000176	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.47e-05	0.000176	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HRAS—uterine cancer	2.46e-05	0.000175	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL8—uterine cancer	2.43e-05	0.000174	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HRAS—uterine cancer	2.42e-05	0.000173	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN1B—uterine cancer	2.42e-05	0.000172	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AKT1—uterine cancer	2.39e-05	0.000171	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN1B—uterine cancer	2.38e-05	0.00017	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AKT1—uterine cancer	2.35e-05	0.000168	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	2.28e-05	0.000163	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTEN—uterine cancer	2.27e-05	0.000162	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CTNNB1—uterine cancer	2.25e-05	0.00016	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTEN—uterine cancer	2.23e-05	0.000159	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTEN—uterine cancer	2.22e-05	0.000159	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTEN—uterine cancer	2.19e-05	0.000156	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AKT1—uterine cancer	2.17e-05	0.000155	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—EP300—uterine cancer	2.17e-05	0.000155	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT1—uterine cancer	2.14e-05	0.000152	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—EP300—uterine cancer	2.12e-05	0.000152	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EP300—uterine cancer	2.12e-05	0.000151	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EP300—uterine cancer	2.09e-05	0.000149	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—uterine cancer	2.01e-05	0.000143	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NRAS—uterine cancer	1.98e-05	0.000142	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—uterine cancer	1.98e-05	0.000141	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NRAS—uterine cancer	1.95e-05	0.000139	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTHFR—uterine cancer	1.86e-05	0.000133	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KRAS—uterine cancer	1.71e-05	0.000122	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KRAS—uterine cancer	1.68e-05	0.00012	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CA—uterine cancer	1.6e-05	0.000114	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CA—uterine cancer	1.57e-05	0.000112	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	1.57e-05	0.000112	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CA—uterine cancer	1.54e-05	0.00011	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—uterine cancer	1.52e-05	0.000108	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—uterine cancer	1.49e-05	0.000107	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HRAS—uterine cancer	1.45e-05	0.000104	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HRAS—uterine cancer	1.43e-05	0.000102	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKT1—uterine cancer	1.31e-05	9.35e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKT1—uterine cancer	1.28e-05	9.16e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT1—uterine cancer	1.28e-05	9.15e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT1—uterine cancer	1.26e-05	9e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTEN—uterine cancer	1.03e-05	7.37e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—EP300—uterine cancer	9.86e-06	7.03e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CA—uterine cancer	7.29e-06	5.2e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKT1—uterine cancer	5.96e-06	4.25e-05	CbGpPWpGaD
